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Abstract 
Propensity score matching (PSM) has been widely used to mitigate confounding in 
observational studies, although complications arise when the covariates used to estimate the 
PS are only partially observed. Multiple imputation (MI) is a potential solution for handling 
missing covariates in the estimation of the PS. Unfortunately, it is not clear how to best apply 
MI strategies in the context of PSM. We conducted a simulation study to compare the 
performances of popular non-MI missing data methods and various MI-based strategies under 
different missing data mechanisms (MDMs). We found that commonly applied missing data 
methods resulted in biased and inefficient estimates, and we observed large variation in 
performance across MI-based strategies. Based on our findings, we recommend 1) deriving the 
PS after applying MI (referred to as MI-derPassive); 2) conducting PSM within each imputed 
data set followed by averaging the treatment effects to arrive at one summarized finding (INT-
within) for mild MDMs and averaging the PSs across multiply imputed datasets before obtaining 
one treatment effect using PSM (INT-across) for more complex MDMs; 3) a bootstrapped-based 
variance to account for uncertainty of PS estimation, matching, and imputation; and 4) 
inclusion of key auxiliary variables in the imputation model. 
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1. Background 
Randomized clinical trials serve as the gold standard for providing strong evidence for the 
effects of new and existing treatments.1 For numerous reasons including ethical and financial 
costs, however, it is not always feasible to conduct such trials. Alternatively, observational 
studies have a long history of providing evidence for comparative effectiveness of treatments 
and interventions, and can also serve as justification for conducting a definitive randomized 
clinical trial.2–4 The presence of confounding, however, can threaten the ability of an 
observational study to draw causal inference.5 Methods based on the propensity score (PS), 
defined as the conditional probability of being assigned a particular treatment given the 
subject’s observed baseline covariates, can be used to mitigate issues of confounding present in 
observational studies.6–8 While the true PS is not typically known, it can be estimated using 
logistic regression or other machine learning techniques.9  PS-based methods include matching, 
inverse probability of treatment weighting (IPTW), stratification or subclassification, and 
covariate adjustment.7,9–11 PS matching (PSM) is one of the more common tools used among 
the PS-based techniques and, thus the primary focus of the study presented here. 
 
By way of background, we can estimate the average treatment effect in the treated (ATT) using 
PSM under the potential outcomes framework.12,13 PSM produces unbiased estimates of the 
ATT, under the assumptions of strongly ignorable treatment assignment (SITA)6, which requires 
1) the exposure to be independent of potential outcomes given a set of covariates 
(unconfoundedness) 2) the probability of receiving each treatment conditional on any set of 
covariates to be strictly between zero and one (positivity), as well as the Stable Unit Treatment 
Value Assumption (SUTVA)14, which states that the outcome of a subject is not affected by the 
treatment assignment of other subjects. Once these assumptions are met, researchers can 
choose from a variety of matching methods. This paper focus on nearest neighbor matching. 
Other choices in matching include greedy or optimal matching, with or without replacement, 
one-to-one or many-to-one matching.15 Individuals with comparable PSs and discordant 
exposures will be matched to achieve balance in covariates in the PS model across the 
comparator groups of interest. One way to ensure quality of matches is to introduce a caliper, 
although this introduces potential bias and inefficiency by discarding treated units outside the 
area of common support.15–18  
 
Once balance of covariates has been achieved in the matched samples, an analysis can be 
conducted to estimate the treatment effect and its variance. In contrast to a simple comparison 
between the treatment groups within the matched samples, a regression-based treatment 
effect estimator removes residual imbalance in covariates between treatment groups by 
adjusting for confounders in the model after matching.15,19,20 The variance estimation of the 
treatment effect in the context of PSM is not straightforward and remains controversial despite 
the large body of literature devoting attention to this issue.15,19,21–30 In addition to the 
uncertainty in the treatment effect estimation, researchers disagree on how to account for 
uncertainty in the PS estimation15,25 or in the matching process21,26,29, if at all. Based on the 
current literature, we considered two variance estimators as relevant choices: a robust cluster 
variance estimator26 to account for the clustering induced by matched observations as well as a 
bootstrapped-based estimator28,31 as it takes into account uncertainties in both the PS 
estimation and the matching process. 
 
The statistical validity of PSM is threatened in the presence of missing data.11,32–34 For example, 
if systematic missingness exists among measured confounders, the estimated ATT may be 
biased. The most common approaches to handling partially observed confounders in PSM 
include complete-case analyses (CC), complete-variable analysis (CVA), and single imputation 
methods.37  In the former, subjects missing at least one confounders are excluded from the 
analysis. 35,36 Importantly, CC produces unbiased estimates when data are missing completely at 
random (MCAR), i.e. missingness is not related to either observed or unobserved data. 
Complete-variable analysis (CVA) involves excluding variables with missingness from the 
analysis, and single imputation methods have been applied in this context although less 
frequently than CC and CVA.37 Multiple imputation (MI) is a reasonably flexible method for 
handling missing data with good statistical properties that leads to unbiased and efficient 
estimators of parameters of interest when the data are missing at random (MAR), or when the 
missingness is related to observed data and not unobserved data conditional on the observed38. 
MI may also be applicable when data are missing not at random (MNAR), or when missingness 
is related to unobserved variables, although researchers either need to explicitly model the 
missing data mechanisms under MNAR.39 The implementation of MI even in the simplest of 
contexts, however, requires that the user make numerous decisions which can greatly impact 
the results.40 Among the two modelling approaches of MI, our study focuses on fully conditional 
specification (FCS) instead of joint modeling (JM) for its flexibility to accommodate multiple 
data types and its increase in application.41  
 
In the context of PSM, MI presents unique issues. To incorporate the PS when using MI, one has 
to (1) estimate the PS and (2) integrate the PS into the analysis to obtain the treatment effect. 
There are multiple options for the estimation step. Specifically, it is not clear whether one 
should impute the confounders first and then estimate the PS, referred to as a passive 
approach40, or whether one should impute the PS as if it were any other variable, referred to as 
an active approach42. The question of imputing in the presence of derived variables is not new 
and has been discussed in previous contexts, including for imputing interaction terms and 
higher-order terms;42–46 however, the approach utilized in the context of PSM has been 
limited.47–49 Active approaches have been promoted as bias-reducing because all variables and 
their interrelationships are considered in the imputation process, reflecting a proper and 
congenial imputation approach.40,50–52 In contrast, passive approaches have been supported 
because they result in internally consistent imputations (where the PS for subjects will perfectly 
correspond to its estimation as a function of their underlying confounders). Regarding the 
integration of PS, one can apply PSM within each imputed dataset and then arrive at an overall 
treatment effect estimate by averaging the effects obtained across imputed data sets (known 
as within integration). Alternatively, one can average the PSs across the imputed data sets, 
obtain one PS before estimating treatment effect from PSM (known as across integration).47–
49,53 
 
We are not the first to consider MI methods when using PSM for causal inference.47–49 
However, significant gaps in methods remain, as work to date has been limited and has 
consisted of only one form of passive imputation (where confounders are first imputed without 
consideration of the PS, which is subsequently estimated) along with within and across 
integration strategies.47–49 We build upon this excellent body of literature by evaluating active 
imputations and variations of passive imputations that allow the consideration of auxiliary 
terms in the imputation model. Further, there is no consensus as to how to best estimate the 
uncertainty of the treatment effect. This paper presents a novel simulation study to 
comprehensively evaluate imputation and integration approaches in the context of PSM for the 
purpose of causal inference. Section 2 details gaps in the current literature that examined MI 
for PSM. Section 3 describes our methods for conducting a simulation study. We present our 
findings in Section 4 and discuss interpretation of our findings that inform best statistical 
practice in Section 5.  
 
 
2. Multiple Imputation Methods for PSM 
MI is a simulation based statistical tool to handle missing data, which involves three main steps. 
In Step 1, multiple sets of plausible values of the missing variable are generated based on the 
posterior predictive distribution of observed variables to reflect the uncertainties of the 
imputation process. In Step 2, analyses are performed within each imputed dataset 
independently, before their results are combined with the application of Rubin’s Rules in Step 
3.54 It has been well established in the MI literature that the outcome should always be 
included in the model when regression parameters are of interest.38,40,55–57 In the context of 
PSM, the various strategies we consider (described below) involve Steps 1 and 3.  
 
With respect to Step 1, there are two broad categories of MI strategies that have been 
introduced in the literature for derived variables or variables that are functions of other 
variables: active (MI-active) and passive (MI-passive) (Figure 1a). Such derived variables include 
interaction terms, higher order terms, ratios of two variables (e.g. body mass index), and rates 
of change.42–46 In MI-active, the derived variable is imputed as if it were any other variable.42 
The simplest, “regular” form of MI-active, MI-regActive, involves calculating the derived 
variable in complete cases and imputing it together with all other missing variables in the 
imputation process, with no consideration of its known relationship to the variables involved in 
its derivation. MI-regActive is a proper imputation method, as all the relationships specified in 
the scientific model are included in the imputation models, i.e. the imputation model is 
congenial with the scientific model.40,50–52 Although MI-active is advantageous for its 
consideration of entire covariance structure, some argue that it undermines the imputation 
process by creating internally inconsistent values. This motivated a re-derived version of MI-
active where the derived variable is recalculated post-imputation (MI-redActive).42 
 
In contrast to MI-active approaches, MI-passive approaches maintain the internal consistency 
between variables used to construct the derived variable and the derived variable itself.40 In 
this case, the derived term is not to be imputed but derived after imputing the variables 
involved in the term’s construction. The simplest form of MI-passive is MI-derPassive, where all 
variables to be used in deriving the term are imputed using MI, before the term is derived from 
the imputed data.42 However, because the derived variable is not included in the imputation 
process, MI-derPassive may be biased, as the process does not consider the entire covariance 
structure of all variables in the scientific model. Another form of MI-passive, MI-regPassive, was 
developed to partially address this issue by including the derived variable in the imputation 
process of those variables (e.g. an auxiliary variable) that are not involved in its derivation.58 
Auxiliary variables are those that can improve imputation through their inclusion in the 
imputation process, but do not provide any useful information for the scientific model.39 For 
example, a variable that is associated with the pattern of missingness or the missing variable 
itself can be considered an auxiliary variable.39 Previous work in MI for PSM has been limited to 
MI-derPassive. Neither MI-regPassive, which involves an auxiliary variable, fully or partially 
observed, nor any active approaches (MI-regActive and MI-redActive) have been considered 
previously for handling missingness in PSM.  
 
PS estimates need to be integrated in the analysis to estimate the treatment effect. There has 
been considerable work in examining integration methods for MI-derPassive. Specifically, the 
PS can be estimated and incorporated within each imputed data set (INT-within) prior to 
obtaining the treatment effect through summarization in Step 3, or the PS can be averaged 
across the imputed data sets after completing Step 1 and applied to the original data set to 
obtain the treatment effect (INT-across).47–49 An additional variation on INT-across, INT-across2 
has been previously applied in the context of IPTW. It involves averaging both the estimated 
regression coefficients corresponding to the covariates used to estimate the PS model and the 
covariates values themselves to arrive at one PS that can be applied to obtain the treatment 
effect.53 The rationale is that the PS coefficients are more suitable for combination using 
Rubin’s Rules given their distributional properties than are the PSs themselves, which are 
confined to be between 0 and 1 (Figure 1b).  
We comprehensively evaluate the different combinations of MI imputation and integration 
strategies described. 
 
How to best estimate the variance of the treatment effect in the context of PSM when applying 
MI is an open research topic.47–49 In addition to the complications in variance estimation in PSM 
mentioned above in the absence of missing data, we need to consider the uncertainty 
introduced by the MI process in the presence of missing data. Rubin’s Rules may be applicable 
to INT-within, however, it is unclear how to capture this uncertainty when using INT-across and 
INT-across2.47–49 Bootstrap methods have been proposed in the context of MI59,60 and 
specifically with respect to PS-based methods49,61. For example, Austin & Small evaluated two 
potential estimators for PSM in the absence of missing data, where the variance was obtained 
by either resampling matched pairs or the original observations.28 Although the former 
performed well relative to the empirical variance, the latter was comparable and enabled 
extension to the MI context.  Schomaker & Heumann evaluated four bootstrapped-based 
approaches in the context of MI when PSM was not considered.59 One of these approaches, 
“Boot MI”, is applicable to the PSM context and overlaps with the ideas described by Austin & 
Small. We therefore compare two competing variance estimators in this study to better inform 
those applying MI in the PSM setting: a bootstrapped-based variance estimator and a robust 
cluster variance estimator (with Rubin’s Rules when applying INT-within) to account for various 
sources of variation when MI is applied in the context of PSM.  
 
 
3. Simulation Study Design 
We conducted an extensive simulation study to assess the performance of various MI-based 
strategies and commonly applied methods when estimating the treatment effect using PSM. In 
all scenarios, we included two binary confounders of the relationship between treatment and 
outcome, a binary variable representing the treatment or exposure of interest, and a 
continuous outcome. Missing values were present in one of the two confounders whereas the 
treatment and outcome variables were always fully observed. For each scenario, 1,000 
simulated data sets were generated, each consisting of 𝑛 = 2000 subjects. All data analyses 
were conducted in R version 3.5.1.62 MI and PSM were implemented using the mice and 
Matching packages respectively.63,64 The R code to replicate this study is publicly available in a 
Github repository at https://github.com/yling2019/psm_mi. Below we provide details on the 
data generation, missing data mechanisms, missing data methods considered, and metrics for 
performance evaluation. 
 
3.1 Data generation  
Confounders. Two binary variables 𝑋 = (𝑋', 𝑋)) that confound the relationship between 
treatment and outcome were generated, by first creating two variables from a bivariate normal 
distribution (correlation of 0.5) each with mean 0 and variance 1, which were then 
dichotomized at the mean.  
 
Treatment indicator. A binary treatment variable 𝑇 was generated from a binomial distribution 
such that:   𝑙𝑜𝑔𝑖𝑡	(𝑝	(𝑇 = 1|	𝑋', 𝑋))) 	= 		 𝛼6 	+	𝛼'𝑋' 	+	𝛼)𝑋)  
where 𝛼' = 𝛼) = 2 so both covariates contributed equally to the treatment assignment. The 
intercept of the treatment 𝛼6	 was selected such that roughly 30% of subjects were treated, to 
reflect real-world datasets where there are often many more control subjects than treated.  
 
Outcome. A continuous outcome variable 𝑌 was generated as a linear function of the treatment 
and both covariates.  𝑌	 = 	𝛽6 	+	𝛽'𝑋' +	𝛽)𝑋) +	𝛽:𝑇	 + 	𝜀 
where 𝛽' = 𝛽) = 2 so both covariates were equally and positively associated with outcome 
and 𝜀	~		𝑁(0, 10)). The intercept 𝛽0 was set to zero and the true treatment effect 𝛽: was set to 
2.  
 
Auxiliary variables. An auxiliary variable 𝑍) was generated to be highly correlated with 𝑋) 
(correlation = 0.98). An additional auxiliary variable 𝑍@A	was generated to be highly correlated 
with the estimated PS score (based on full observed data, with correlation of 0.98). More 
specifically, setting ẟ6) = 1, ẟ6@A = 0, ẟ') = ẟ'@A = 10, the auxiliary variables were generated 
as: 
𝑍) 	= 	ẟ6) +	ẟ')𝑋) 	+ 	𝜀 𝑍@A 	= 	ẟ6@A +	ẟ'@A𝑃𝑆D 	+ 	𝜀 
where 𝜀	~	𝑁(0, 1)). 
 
3.2 Missing data mechanisms (MDMs) 
Missingness was always induced in 𝑋), whereas 𝑋'	was fully observed. We induced missing data 
in 𝑋)	according to five different mechanisms: MCAR, MAR1, MAR2A, MAR2B and an MNAR 
scenario. Whereas MAR1 represented a simple MAR scenario, MAR2A and MAR2B were more 
sinister scenarios that captured the complexity of MDM in real-world datasets. In MAR1, 
MAR2A, and MNAR, missingness was related to treatment and outcome. In MAR2A, 
missingness was also related to 𝑍), the auxiliary variable associated with 𝑋). In MNAR, 
missingness was also related to 𝑋). Let 𝑅) be an indicator variable denoting whether 𝑋) is 
missing (𝑅) = 1) or not (𝑅) = 0). We set 𝑌F and 𝑍)F to be dichotomizations at the median of 
the outcome variable Y and auxiliary variable 𝑍)	respectively. Under each MDM, the intercept 𝛾6 was selected such that 50% of the observations were missing. Let 𝛾'' 	= 	5, 𝑎𝑛𝑑	𝛾66 	= 	1, 
and 𝐼	be an indicator variable. Missingness in 𝑋) was induced as follows: 
 
MAR1: 𝑙𝑜𝑔𝑖𝑡(𝑅) = 1) = 		 𝛾6 +	𝛾''𝐼:L',MFL' + 𝛾66𝐼:L6,MFL6	 
 
MAR2A: 𝑙𝑜𝑔𝑖𝑡(𝑅) = 1) = 		 𝛾6 + 𝛾''𝐼:L',MFL',N)FL' + 𝛾66𝐼:L6,MFL6,N)FL6  
 
MNAR: 𝑙𝑜𝑔𝑖𝑡(𝑅) = 1) 	= 		 𝛾6 + 𝛾''𝐼:L',MFL',O)L' + 𝛾66𝐼:L6,MFL6,O)L6 
 To study the impact of having a partially observed auxiliary variable, we also induced 
missingness in 𝑋)  according to a second MAR2 missing mechanism, MAR2B, based on 
treatment, outcome, and PS. Letting 𝑍@AF	be the dichotomizations of 𝑍@A, missingness in 𝑋)  was 
induced as follow: 
 
MAR2B: 𝑙𝑜𝑔𝑖𝑡(𝑅) = 1) 	= 		 𝛾6 + 𝛾''𝐼:L',MFL',N@AFL' + 𝛾66𝐼:L6,MFL6,N@AFL6  
 
Additionally, we induced missingness in the auxiliary variable, 𝑍@A, under three scenarios that 
assumed MAR2B for 𝑋): aux_MCAR, aux_MAR1, and aux_MAR2. In both aux_MAR1 and 
aux_MAR2, missingness was related to 𝑇	and 𝑃𝑆F, where 𝑃𝑆F is the dichotomization at the 
median of the PS estimated using full data prior to inducing missingness. Let 𝑅N be an indicator 
variable denoting whether 𝑍@A	is missing (𝑅N = 1) or not (𝑅N = 0). The intercept term e6  was 
selected to ensure 20% missingness in 𝑍@A and missingness can be expressed as:  
 𝑙𝑜𝑔𝑖𝑡(𝑅N = 1) = 		 e6 	+	e''𝐼:L',@AFL' + e'6𝐼:L',@AFL6 + e6'𝐼:L6,@AFL' + e66𝐼:L6,@AFL6  
where e'' = 5, e'6 = 0, e6' = 0, e66 = 5 in aux_MAR1 and e'' = 0, e'6 = 5, e6' = 5, e66 = 0 in 
aux_MAR2. 
 
3.3 Missing data methods   
Common missing data methods. We applied various missing data methods that are widely used 
in the medical research literature including CC, CVA, mean imputation, and the use of missing 
data indicators.  
 
Multiple imputation strategies. Figure 1 displays the MI strategies considered for PS estimation 
and integration. MI-derPassive, MI-regActive, and MI-redActive were applied under MCAR, 
MAR1, MAR2A, and MNAR conditions with or without auxiliary variable 𝑍) in the imputation 
model, where 𝑍) had no missing values (Table 1). Under the MAR2B MDM, we included an 
additional partially observed auxiliary variable 𝑍@A in the imputation model when MI-regPassive 
and MI-derPassive were applied. Under this scenario we also examined performance by order 
of inclusion of the variables in the imputation model (i.e., whether 𝑋)  was imputed before 𝑍@A 
or not). Integration approaches considered were INT-within, INT-across, and INT-across2. Note 
that INT-across2 cannot be combined with MI-regActive, as the PS was directly imputed from 
MI in MI-regActive. In MICE, 50 multiply imputed datasets (𝑚	 = 	50)43, five iterations 
(𝑚𝑎𝑥𝑖𝑡	 = 	5) and default settings for imputation method (predictive mean matching for 
continuous variable and logistic regression for binary) were used. The outcome was included in 
all imputation models.40 
 
3.4 PSM and treatment effect estimation 
We estimated coefficients 𝛼' and 𝛼)  using a correctly specified logistic regression model, 𝑙𝑜𝑔𝑖𝑡	(𝑝(𝑇 = 1	|	𝑋	)) 	= 	𝛼6 +	𝛼'	𝑋' 	+	𝛼)𝑋).  PS scores were estimated as the fitted values 
of the regression model on the response scale. One-to-one nearest neighbor matching without 
replacement was applied. Subjects were matched by PS scores with calipers of width that is 0.2 
of the standard deviation of the logit of the propensity score.16,65 After matching subjects, the 
treatment effect was estimated using standard linear regression methods, by regressing 𝑌 on 𝑇 
and confounders 𝑋' and 𝑋) to obtain the estimate for the beta coefficient representing 𝑇26 
with the exception of cases where INT-across was applied, as in the presence of multiple data 
sets, there were multiple sets of 𝑋' and 𝑋). 
 
3.5 Variance estimation 
In the absence of missing data, we used two approaches to estimate the uncertainty of the 
treatment effect: (1) a robust cluster variance estimate66 that accounts for the matched design 
and (2) a bootstrapped variance calculated as the standard deviation of treatment effects in 
1,000 bootstrapped samples to account for both PS estimation and the matching process. 
When commonly applied missing data methods were considered, the robust cluster variance 
estimator was used. When MI was applied in the context of PSM, we compared 1) the robust 
cluster variance estimator and 2) a bootstrapped variance. For the former, when the 
integration strategy was INT-within, a robust cluster variance was estimated within each of the 𝑚 imputed dataset, before application of Rubin’s Rules to yield one final variance. For both INT-
across and INT-across2, Rubin’s Rules do not apply; instead we obtain only one robust cluster 
variance. For the latter, the detailed procedure is described as follows: 
1. Sample with replacement 𝑛 = 2000 rows from the observed dataset 𝐷 = (𝑋, 𝑇, 𝑌, 𝑍, 𝑅) 
to obtain a bootstrapped dataset 𝐷F which contains missing values; 
2. Impute 𝑚 datasets for 𝐷F using the imputation strategy (MI-derPassive, MI-regPassive, 
MI-regActive, or MI-redActive), for 𝑘	 = 	1,2, . . . , 𝑚, denoted as 𝐷F(𝑘); 
3. Apply the integration approach (INT-within, INT-across or INT-across2) to obtain a single 
effect estimate for 𝐷F; 
4. Repeat steps 1-3 𝐵 times to obtain 𝐵 bootstrap replicates from which treatment effect 𝛽:F can be estimated for a given bootstrap sample 𝐷F; 
5. Calculate bootstrapped standard error as the standard deviation of B treatment effects 
estimated from each bootstrap sample: 𝑆𝐸FVV:A:WX@ 	= 	𝑠𝑑(𝛽:F)	𝑓𝑜𝑟	𝑏	 = 	1,2, . . . , 𝐵 
 
3.6 Performance metrics 
After PSM, we examined the percentage of treated subjects matched and the standardized 
differences of covariates after matching. For mean imputation, standardized differences were 
calculated in the original full data and the imputed data. For missing indicator variables, 
standardized differences were calculated in the full data without missingness, as well as its 
observed and missing part. For INT-within, standardized differences were calculated in 1) each 
of the imputed datasets 2) the full dataset. For INT-across and INT-across2, standardized 
differences were calculated in 1) the average of 𝑚 imputed dataset and its observed and 
imputed parts respectively 2) the full dataset.53,55 For each missing data method, we report on 
bias, variance, mean squared error (MSE), relative MSE (relative to PSM in the full dataset), and 
coverage probability summarized over 1,000 simulations per scenario. The robust cluster 
variance and bootstrapped variance were compared to their corresponding empirical variance 
for each MI strategy. Coverage was estimated as the proportion of 1,000 simulations such that 
the interval [𝛽:^ − 1.96	 × 	𝑆𝐸, 𝛽:^ + 1.96	 × 	𝑆𝐸] contained the true treatment effect of  𝛽: = 2 
(𝑆𝐸: robust cluster standard error or bootstrapped standard error). We used the normal theory 
estimator because the percentile based method didn’t not perform well in simulations by 
Austin & Small28, and calculating accelerated and bias-corrected confidence intervals (BCa)31 is 
too computationally intensive. Monte Carlo standard errors were calculated for bias, empirical 
standard error, MSE, and coverage.67 Reference metrics for missing dat methods were based on 
applying PSM to the full data (PSM_full).  
 
 
4. Results 
We validated the data generation process by comparing the resulting bias and standard error 
from fitting the true data generating model to that obtained from applying PSM to the full data 
(PSM_full). Both methods yielded unbiased treatment effect estimates (bias = -0.006 in both 
cases). PSM yielded a higher standard error as expected due to discarding unmatched samples 
(0.313 using regression in the full dataset and 0.380 using PSM_full). Coverage reached the 
nominal level of 95% using both methods. These results matched well with their corresponding 
empirical standard error (0.306 and 0.376 respectively). In PSM, the robust cluster standard 
error and bootstrapped estimators were comparable (0.380 in both cases) and close to the 
empirical (0.376).  
 
4.1 Commonly applied missing data methods 
Of the commonly applied approaches, CC had the most favorable MSE relative to that the of 
PSM_full (rMSE = 1.857 to 48.658, Appendix Table A1). CC produced biased treatment 
estimates (bias = -2.489, -0.815, and -1.084 in MAR1, MAR2A, and MNAR respectively) and less 
efficient estimates relative to PSM_full (robust standard error =0.537, 0.838, 0.682, 0.682 in 
MCAR, MAR1, MAR2A and MNAR respectively vs 0.380 in PSM_full). CVA, mean imputation, 
and the use of missing indicators yielded greater bias relative to CC (5.058 to 5.059 for CVA; 
2.985 to 5.759 for mean imputation; and 2.973 to 5.534 for missing indicator), although their 
robust cluster variances were smaller than that of CC. Comparisons of statistical properties 
obtained when not adjusting for	𝑋' and 𝑋)  were similar. 
 
4.2 Variance estimation in MI-based strategies 
While the robust cluster variance estimator and the bootstrapped-based variance estimator 
were comparable in the absence of missing data, differences were observed in the presence of 
missingness and when MI was applied. Specifically, the robust cluster variance estimator 
consistently underestimated the empirical variance in INT-across approaches. Among the INT-
across approaches, the ratio of the robust variance to the empirical exceeded 0.8 only when an 
auxiliary variable was included (Figure 2). The worst performance for the robust estimator was 
observed in MI-regActive INT-across approaches, where the variance ratios were lower than 
0.1. In contrast, the variance was consistently overestimated in INT-within approaches, where 
the variance ratio surpassed 5 under MI-regActive and MI-redActive approaches, especially 
when an auxiliary term was used. The ratio of the robust estimator for the variance relative to 
the empirical under INT-across2 was close to 1 across all MI methods and MDMs. On the other 
hand, the bootstrapped-based variance was more comparable to the empirical variance across 
all MI integration strategies; the ratio of bootstrapped variance to the empirical ranged from 
0.675 to 1.875, with mean 1.01. We did not observe any trend specific to imputation methods, 
integration methods, or the inclusion of auxiliary variable in the imputation model.  All 
subsequent results were therefore calculated using the bootstrapped-based variance estimator.  
 
4.3 Comparing various MI strategies  
For simplicity, we start by describing performance of MI strategies under MAR2A, as MAR2A 
was induced to reflect a realistic but complex MDM. For all MI strategies, balance was achieved 
such that the absolute standardized difference in 𝑋' and 𝑋) between treated and controls 
based on the imputed dataset was below 0.1 with the exception of MI-regActive in the 
presence of an auxiliary term (Appendix Table A2). Performance between MI-derPassive INT-
across and MI-redActive INT-across2 was comparable; both were top performers when 
considering both bias and efficiency. Specifically, MI-derPassive across achieved the lowest 
rMSE (10.073), followed by MI-redActive INT-across2 (10.435) and MI-derPassive INT-across2 
(11.717) (Table 2 and Figure 3). Performance under MI-derPassive and MI-regActive strategies 
was consistent across integration approaches, with the former identified as having among the 
best statistical properties and the latter as performing poorly with respect to both bias and 
efficiency. In contrast, the performance of MI-redActive varied by integration approach, where 
MI-redActive INT-within was the worst performer (rMSE=87.819, bias= 3.433) and MI-redActive 
INT-across2 was the second-best performer (rMSE=10.435, bias= -0.950). INT-across2, INT-
across, INT-within were ranked from the lowest to the highest with respect to rMSE, which was 
largely driven by the bias.  
 
4.4 The impact of auxiliary terms  
Under MAR2A, when a fully observed auxiliary term, 𝑍), was included in the imputation model, 
considerable variation was observed. MI-derPassive INT-across (rMSE= 1.027, bias = 0.039), MI-
redActive INT-across (rMSE= 1.056, bias=0.045), and MI-derPassive INT-within (rMSE = 1.672, 
bias = 0.319) were the top three performing MI strategies in terms of rMSE (Table 2 and Figure 
3). Interestingly, including an auxiliary term improved the rMSE for all strategies, except for MI-
redActive INT-across2 and MI-derPassive INT-across2, the top two performing strategies when 
the auxiliary variable was not included. The auxiliary term improved efficiency for most MI 
strategies except for MI-regActive INT-across. The auxiliary term improved the absolute bias for 
most MI strategies except for MI-redActive INT-across2 and MI-derPassive INT-across2. 
Inclusion of the auxiliary variable was required to obtain nominal level of coverage probability 
in both MAR2A and MNAR (Figure 4). 
 
The performance of MI strategies is shown in Appendix Table A4 and Figure 5 under a modified 
MAR2 scenario (MAR2B) where missingness was a function of a different auxiliary variable, 𝑍@A, 
treatment, and outcome. For reference, we first evaluated performance of passive approaches 
when 𝑍@A was fully observed. MI-derPassive INT-within achieved the lowest rMSE and bias 
(rMSE=1.032, bias=-0.019), followed by INT-across (rMSE=1.394, bias=-0.205), and INT-across2 
(rMSE= 10.319, bias=-1.016). The bootstrapped standard error was the largest in INT-across2 
(0.677) and comparable for INT-within (0.378) and INT-across (0.380). When 𝑍@A was partially 
observed, MI-derPassive and MI-regPassive were largely comparable. Although INT-across 
methods yielded the smallest bootstrap standard error, INT-within methods resulted in smaller 
bias and MSE. While imputing 𝑋) before or after 𝑍@A affected the resulting bias, bootstrap 
standard error and MSE, the order did not change our conclusions on the best performing 
imputation and integration MI strategies as mentioned above. 
 
4.5 Comparison across MDMs 
When auxiliary variables were not incorporated into the imputation model, MI-derPassive 
outperformed MI-redActive, followed by MI-regActive in terms of rMSE, bias, and efficiency 
(Appendix Table A3 and Figure 3, Figure 4). While MI-derPassive INT-within demonstrated 
strong performance regardless of the presence of an auxiliary term under MCAR and MAR1, MI-
derPassive INT-across outperformed INT-within under MAR2A and MNAR, especially when an 
auxiliary variable was included in the imputation model. Inclusion of an auxiliary variable did 
not greatly improve properties of the top performers under MCAR and MAR1. In contrast, the 
performance of MI-strategies was much improved under MAR2A and MNAR, where 
missingness was related to the auxiliary variable. 
 
 
5. Discussion 
We investigated several pragmatic research questions concerning how to optimally apply MI 
when utilizing PSM in the presence of a partially observed confounder. We compared the 
performance of non-MI missing data methods that are commonly applied along with various 
MI-based strategies that vary both in how the PS is estimated or imputed and in how the PS is 
integrated into the analysis. In addition, we evaluated the impact of inclusion of an auxiliary 
term in the imputation model on the ranked performance of the strategies as well as the 
impact of the order of inclusion when there is more than one variable with missing data. 
Among the commonly applied missing data methods, CVA and single imputation methods 
(mean imputation and missing indicator imputation) led to large bias in our simulation study. In 
contrast, CC was not as biased due to the use of a caliper that ensured only those subjects with 
closely matched PSs were included. CC did, however, suffer from loss of efficiency. There was 
large heterogeneity among the MI strategies considered. While MI-derPassive INT-within 
performed well in MCAR and MAR1, inclusion of the auxiliary variable in the imputation model 
was necessary to achieve nominal coverage under MAR2A and MNAR. Based on our results, we 
recommend applied researchers to 1) adopt MI-derPassive approaches; and 2) consider INT-
within for mild MDMs (MCAR and MAR1) and INT-across for MDMs that are more complex. We 
note that this choice requires deep thought into the MDM and relies on unverifiable 
assumptions and our understanding of the nature of the study and variables involved. 
Sensitivity analyses that demonstrate no difference may be reassuring, whereas those that 
highlight differences may reflect incorrect assumptions about the MDM. We also recommend 
3) use of the bootstrap to estimate variance; and 4) inclusion of key auxiliary variables in the 
imputation model if available.  
 
Our study is important in identifying the limitations of commonly applied methods. 
Considerable bias and inefficiency were observed among all commonly applied methods 
relative to that yielded by applying PSM to the data set with no missing values. At least one of 
the MI-based strategies always outperformed the commonly applied methods. Importantly, 
when applying PSM, it is well established that balancing diagnostics are useful tools to guide 
analyses, and this proves difficult with commonly applied methods. In particular, if balance -- as 
reflected by standardized differences in covariates -- is not achieved, additional differential 
modeling of the PS should be considered. It is important to note, however, that in the presence 
of missing data, simple diagnostics are not straightforward to obtain. For example, while CC can 
be applied using those matched pairs where balance is achieved, bias may still occur because of 
the observations not included due to missingness. For missing indicators, we were unable to 
achieve balance in the variable with missing data, as revealed in our simulations when we 
parsed the data by observed and missing data to evaluate balance in these respective parts. 
Thus, in practice, one may have a false sense of the balance as the user is only privy to assessing 
the balance in the observed data. Similarly, application of mean imputation distorts the 
distributional properties of the variable with missing data, potentially yielding a distorted view 
of balance when the imputed values are utilized in calculating the standardized differences 
(Appendix Table A1). Finally, for CVA, a false sense of security may be given when evaluating 
balance in only one variable, when exclusion of the other variable could lead to bias.  
 
We have primarily examined the differences between passive and active MI methods when a 
derived variable, such as PS, was considered in the analysis and only partially observed. MI-
derPassive methods surpassed MI-regActive approaches in almost all performance metrics 
across all MDMs. Although active MI methods were proposed so the entire covariance structure 
of all variables including the PS itself could be retained, the covariance structure between PS 
and the PS variables is complex and difficult to learn using complete cases only. Unlike usual 
derived measures (e.g. interactions and higher order terms) that are derived as a simple 
function of other variables, PSM requires estimation. In this way, PS is different from other 
derived variables in that the exact function will vary depending on the data considered. This 
was particularly relevant for MDMs that were not MCAR, where PS -- estimated from complete 
cases may be biased depending on the MDM – introducing further bias into the imputation 
procedure and consequently the treatment effect. Such bias was also reflected in the difficulty 
to achieve balance both in the imputed and fully observed data under MI-regActive (Appendix 
Table A2). Further, the poor estimation of the treatment effect has implications for estimates 
of uncertainty. More specifically, the bootstrapped-based variance involves multiple draws of 
the data with application of MI-regActive coupled with PSM performed on each draw. As the 
bias introduced in the estimation of the treatment effect highly varies across the draws, this 
leads to an increased estimate of the variation (Appendix Figure A1). Although adding an 
auxiliary variable reduced bias for most of the cases, it did not help reduce bias for the extreme 
cases where the bias without auxiliary variable was unexpectedly high. Nevertheless, this 
problem might not be as profound in real data analyses where there a larger number of 
covariates are typically included in the PS model. In contrast, MI-redActive can be thought of as 
a hybrid between MI-derPassive and MI-regActive and mitigated this issue by re-deriving PS 
post-imputation, as in MI-derPassive. Although MI-derPassive still outperformed or performed 
comparably to MI-redActive methods in our simulations, our findings demonstrated that MI-
active approaches hold great promise in recovering the underlying covariance structure 
especially when there are higher dimensional data and more flexible models are being 
considered. 
 
Although we found MI-derPassive to be the optimal MI method for PSM with partially observed 
covariates, there are several considerations including the integration choice. While Mitra & 
Reiter recommended INT-across, de Vries & Groenwold found INT-within to yield estimators 
with better statistical properties.48,49,57 In a different setting (IPTW instead of PSM), Leyrat et. 
al. demonstrated superior properties of INT-within methods over INT-across and INT-across2.53 
Our results varied across MDMs and were consistent with Leyrat and others and de Vries & 
Groenwold under MCAR and MAR1 but corroborated with those of Mitra and Reiter under 
MAR2A and MNAR conditions. We also share the perspective of Leyrat and others53 that it was 
more straightforward to assess balance in INT-within strategies and observed that the 
covariates were mostly balanced in both the imputed and full data sets (Appendix Table A2). 
Further, Leyrat and others pointed out that the INT-across and INT-across2 produced consistent 
estimators only when both the observed and imputed data were balanced.53 We therefore paid 
close attention to balance diagnostics for INT-across and INT-across2 methods but did not 
observe balance in both parts of the data (observed and missing) under all MDMs other than 
under MCAR.  
 
An important contribution of our paper is resolution of how to estimate the variance when 
doing PSM and applying MI. There has been extensive but conflicting research on this topic in 
the context of MI and IPTW where Rubin’s Rules have been recommended for INT-within by 
some authors53,68 and a bootstrapped-based estimator was recommended by others61. Relative 
to IPTW, however, we are faced with the additional issue of capturing the uncertainty of 
matching in PSM. Prior studies of MI applications in the context of PSM acknowledged this 
issue47,48, but only one study has explicitly stated their recommendation of a bootstrapped-
based variance49, although the choice was not studied comparatively or discussed fully. In our 
study, we found that application of Rubin’s Rules when the robust cluster estimator was used 
for each imputed data set overestimated the variance under INT-within approaches and 
underestimated it under INT-across approaches. We therefore agree with de Vries & 
Groenwold49 in recommending the bootstrapped variance, as it captures the uncertainty of PS 
estimation, matching procedure, and imputation process. Further, it demonstrated good 
performance with respect to the empirical variance. We acknowledge the lack of theoretical 
support for this choice, which comes with challenges, as the estimator for the treatment effect 
based on PSM and MI is not a smooth function. Although Abadie & Imbens24 proved that the 
bootstrap variance is not valid in matching with replacement, their results may not be 
applicable in our study when matching was done without replacement, where one control unit 
can only be used for matching at most once28. Other alternative non-parametric solutions with 
stronger theoretical justification, such as subsampling, has their own limitations (e.g. the need 
for a sufficiently large sample size and a burden on the user to appropriately select a sub-
sample and replication size).69 
 Auxiliary variables are often useful for adhering to a MAR MDM, but not always possible in the 
context of PSM. Specifically, variables related to partially observed confounders may be 
considered confounders themselves and thus, may not exist outside of estimation of the PS. 
Our team has worked on studies, however, where auxiliary terms may be available. For 
example, in a comparative effectiveness study of anticoagulants among kidney transplant 
patients, a PS that balances patient characteristics may include body mass index (BMI) at 
treatment initiation but not BMI at transplant listing. The latter is an excellent candidate for an 
auxiliary variable that can aid in imputing BMI at treatment initiation as well as other PS 
covariates. By including a strong auxiliary variable in the imputation process, we showcased the 
maximal performance improvement given any auxiliary variable. In practice, the strength of 
auxiliary variable varies and consequently the improvement in performance may be moderate. 
 
There are several limitations to our study. As with any simulation study, we recognize that the 
limited scope of our simulations may compromise generalizability. Specifically, only two 
covariates were included in the PS, and there were only main effects in the data generating 
mechanism. We also only considered the scenario when one confounder was partially 
observed, whereas missingness of covariates that are not confounders, treatment or outcome 
was not considered.47,49,68 Whether our findings extend to binary or time-to-event outcomes 
remains to be studied, since odds ratios and hazard ratios are not collapsible.70 Nevertheless, 
some of our findings agree with those from simulation studies on binary outcomes in a similar 
context (IPTW).53,68 Finally, we did not explore the impact of mis-specifying the correct PS 
model or having completely missing covariates.  
 
Overall, we have addressed an important topic – how to apply MI strategies in the presence of 
missing values in confounders in the context of PSM. Our work will facilitate future applied 
researchers’ choice of optimal missing data methods in all kinds of statistical analyses that 
involve PSM. In addition to classical causal inference settings, our results are applicable to other 
types of studies that utilize PSM including those that generalize randomized clinical trial 
findings to real-world target populations captured in observational databases.71,72 
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Figures  
 
 
Figure 1. Illustration of various multiple imputation (MI) imputation and integration strategies 
in the context of our simulation study. Figure 1(a) above details three imputation strategies: 
MI-derPassive, MI-regActive, and MI-redActive. Text in red indicates the values that are 
imputed, while text in blue indicates the values that are derived. MI-redActive shares the same 
two steps with MI-regActive, but it discards the PS values output from MI and re-derives PS 
post-imputation. Figure 1(b) below illustrates three integration strategies: INT-across, and INT-
across2, INT-within. Imputed values are colored in red. For INT-across, PSM analysis was 
conducted after PSs are averaged over 𝑚 imputed datasets. For INT-across2, PS was estimated 
using the average PS coefficients and average covariates followed by PSM. Note that MI-
regActive cannot be applied in combination with INT-across2. For simplicity and without loss of 
generality, the above illustration does not involve inclusion of auxiliary variables in the 
imputation model. 
 
 
Figure 2. Comparing robust cluster variance and bootstrap variance to empirical variance in 
various MI strategies in all four missing data mechanisms. Variance ratios were calculated by 
dividing the two variance estimates with the corresponding empirical variance of each specific 
MI strategy varying imputation methods, integration strategies, with or without auxiliary 
variable in the imputation model. The 95% confidence interval estimated using the 2.5% and 
97.5% percentile of the variance estimated from 1,000 simulations are illustrated for each MI 
method as well. Note that some of the variance ratios above 5 are not shown. 
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Figure 3. Average bias and variance estimated from 1) full data without missingness 2) 
commonly applied missing data methods including complete case analysis, complete variable 
analysis, mean imputation and missing indicator 3) various multiple imputation (MI) strategies 
paired with integration strategies, averaged from our 1,000 simulations in our four missing data 
mechanisms. Results of methods with variance larger than 1 is not shown on the plot but are 
recorded in Table 2 and Table A2. For 1) and 2), the robust cluster variance was plotted as this 
is what applied researchers would use in practice. For 3) the bootstrapped variance was plotted 
as this is our recommended variance estimator. The vertical and horizontal grey dotted lines 
indicate the average bias and variance obtained by applying PSM to the full data. 
  
 
Figure 4. Coverage probability of 1) full data without missingness 2) commonly applied missing 
data methods including complete case analysis, complete variable analysis, mean imputation 
and missing indicator 3) various multiple imputation strategies paired with integration 
strategies from our 1,000 simulations in our four missing data mechanisms. For 1) and 2) the 
coverage was calculated using average bias and robust cluster variance and for 3) the coverage 
was calculated using average bias and bootstrapped variance. The grey dotted line is at 
coverage = 0.95. 
  
 
Figure 5. Average bias and bootstrap variance estimated when 𝑋) was missing MAR2B (when 
the missingness of 𝑋) was related to treatment, outcome, and 𝑍@A as described in the Methods 
section) and MI-derPassive and MI-regPassive were applied, averaged from out 1,000 
simulations across three missing data mechanisms for auxiliary variable 𝑍@A. The top three plots 
show results when 𝑋) was imputed before 𝑍@A in the imputation process, and such order is 
reversed in the bottom three plots. The vertical and horizontal grey dotted lines indicate the 
average bias and variance obtained by applying PSM to the full data. 
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Tables 
Table 1 
Comparison of the different predictors included in the imputation model for the multiple 
imputation approaches included 
Scientific model: 𝑌	~	𝑇	 +	𝑋' +	𝑋) 
Missing 
Variable 
Predictors in imputation model 
MI-regActive MI-redActive* MI-derPassive MI-regPassive*** 𝑋) 𝑋', 𝑇, 𝑌, 𝑃𝑆	(𝑍)	) 𝑋', 𝑇, 𝑌, 𝑃𝑆	(𝑍)) 𝑋', 𝑇, 𝑌, (𝑍)	𝑜𝑟	𝑍@A) 𝑋', 𝑇, 𝑌, 𝑍@A 𝑃𝑆 𝑋', 𝑋), 𝑇, 𝑌	(𝑍)) 𝑋', 𝑋), 𝑇, 𝑌(𝑍)) - - 𝑍** - - 𝑋', 𝑋), 𝑇, 𝑌 𝑋', 𝑋), 𝑇, 𝑌, 𝑃𝑆 
*𝑃𝑆 is re-derived from 𝑋' and 𝑋)  after MI procedure  
** 𝑍) was used in MI-derPassive, MI-regActive, and MI-redActive when it was fully observed. 𝑍@A was used in MI-derPassive and MI-regPassive when 20% of values were missing. Under 
MAR2B, the order of imputation (whether 𝑍@A was imputed before or after 𝑋)) was also 
evaluated.  
*** The steps within MICE algorithm for MI-regPassive are described as follows (when 𝑋)  was 
imputed before 𝑍@A): 1) impute 𝑋), with 𝑋', 𝑇, 𝑌 and 𝑍@A 2) derive 𝑃𝑆 from 𝑋' and 𝑋) 3) impute 𝑍@A  with 𝑋', 𝑋), 𝑇, 𝑌, and 𝑃𝑆. 
 
Table 2. Bias, standard error mean squared error (MSE), relative mean squared error (rMSE), 
and coverage results of various multiple imputation strategies under MAR2A (Monte Carlo 
standard errors in parentheses). 
MI Strategy  Standard Error    
Imputation Integration Bias Empirical Bootstrap MSE rMSE Coverage 
Auxiliary variable not included in imputation model 
   MI-derPassive INT-within 1.479 (0.016) 0.511 (0.011) 0.470 (0.002) 2.448 (0.051) 17.341 0.001 (0.001) 
 INT-across 1.094 (0.015) 0.476 (0.011) 0.473 (0.002) 1.422 (0.036) 10.073 0.107 (0.010) 
 INT-across2 -1.037 (0.024) 0.761 (0.017) 0.671 (0.003) 1.654 (0.053) 11.717 0.957 (0.006) 
MI-regActive INT-within 3.258 (0.022) 0.684 (0.015) 0.582 (0.007) 11.081 (0.128) 78.497 0 (0) 
 INT-across 2.252 (0.050) 1.587 (0.036) 1.769 (0.048) 7.587 (0.663) 53.746 0.539 (0.016) 
MI-redActive INT-within 3.433 (0.025) 0.781 (0.017) 0.605 (0.008) 12.397 (0.181) 87.819 0 (0) 
 INT-across 2.001 (0.026) 0.818 (0.018) 0.805 (0.009) 4.674 (0.146) 33.110 0.198 (0.013) 
 INT-across2 -0.950 (0.024) 0.756 (0.017) 0.654 (0.002) 1.473 (0.049) 10.435 1 (0) 
Auxiliary variable included in imputation model 
   MI-derPassive INT-within 0.319 (0.012) 0.366 (0.008) 0.378 (0.001) 0.236 (0.009) 1.672 1 (0) 
 INT-across 0.039 (0.012) 0.379 (0.008) 0.380 (0.001) 0.145 (0.006) 1.027 1 (0) 
 INT-across2 -1.104 (0.024) 0.756 (0.017) 0.677 (0.003) 1.789 (0.057) 12.673 0.954 (0.007) 
MI-regActive INT-within 0.419 (0.012) 0.394 (0.009) 0.406 (0.001) 0.331 (0.012) 2.345 1 (0) 
 INT-across 1.642 (0.120) 3.807 (0.085) 3.516 (0.057) 17.172 (1.684) 121.645 0.991 (0.003) 
MI-redActive INT-within 0.418 (0.012) 0.381 (0.009) 0.389 (0.001) 0.320 (0.011) 2.267 1 (0) 
 INT-across 0.045 (0.012) 0.383 (0.009) 0.388 (0.001) 0.149 (0.007) 1.056 1 (0) 
 INT-across2 -1.073 (0.023) 0.741 (0.017) 0.682 (0.002) 1.700 (0.056) 12.043 0.995 (0.002) 
 
 
  
Appendix 
Figure A1. Illustration of bias in estimated treatment effects in 1,000 simulations MI-regActive 
when	𝑋) was missing under MNAR. The bias from each simulation when auxiliary variable was 
not included (black dots) was ranked from the lowest (left) to the highest (right). The red dots 
indicate the bias from the same simulation but when the auxiliary variable was included. We 
can see that, including an auxiliary variable reduces bias in most cases, except in the 
simulations with extremely high bias (right hand side of the plot). This explains why including an 
auxiliary variable increased the bootstrap variance as seen Appendix Table A3. 
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Table A1. Balance diagnosis and treatment effect estimation results using commonly applied 
missing data method before propensity score matching (PSM), in reference to applying PSM to 
full data without missingness (Monte Carlo standard errors in parentheses).CC = complete-case 
analysis, CVA = complete-variable analysis.  
   Stanford Error     
Post-Matching Standardized 
Difference 
MDM Method Bias Empirical Robust MSE rMSE Coverage 
Percentage 
Matched 
Underlying 
data X1 X2 
Full 
Data NA 
-0.006 
(0.012) 
0.376 
(0.008) 
0.380 
(0.001) 
0.141 
(0.006) 1.000 
0.950 
(0.006) 0.653 - 0.000 0.000 
MCAR CC 
0.002 
(0.011) 
0.513 
(0.011) 
0.537 
(0.001) 
0.262 
(0.007) 1.857 
0.957 
(0.006) 0.653* - -0.001 -0.004 
 CVA 
5.058 
(0.013) 
0.436 
(0.01) 
0.442 
(0) 
25.772 
(0.132) 182.565 0 (0) 0.960 - 0 0.947 
 
Mean 
Imputation 
2.985 
(0.014) 
0.461 
(0.01) 
0.447 
(0.001) 
9.122 
(0.084) 64.617 0 (0) 0.803 original data 0 0.546 
         imputed data 0 0 
 
Missing 
Indicator 
2.973 
(0.016) 
0.440 
(0.01) 
0.446 
(0.001) 
9.032 
(0.098) 63.981 0 (0) 0.535 full data 0 0.546 
         observed part 0 0 
         missing part 0 0.946 
MAR1 CC 
-2.489 
(0.017) 
0.821 
(0.018) 
0.838 
(0.002) 
6.869 
(0.088) 48.658 
0.157 
(0.012) 1.000* - 0.002 -0.001 
 CVA 
5.059 
(0.013) 
0.434 
(0.01) 
0.443 
(0) 
25.782 
(0.131) 182.634 0 (0) 0.960 - 0 0.948 
 
Mean 
Imputation 
5.759 
(0.017) 
0.573 
(0.013) 
0.497 
(0.004) 
33.498 
(0.195) 237.298 0 (0) 0.735 original data 0 1.206 
         imputed data 0 0.095 
 
Missing 
Indicator 
5.201 
(0.025) 
0.686 
(0.015) 
0.674 
(0.001) 
27.517 
(0.267) 194.929 0 (0) 0.271 full data 0 0.936 
         observed part 0 0.034 
         missing part 0 1.517 
MAR2A CC 
-0.815 
(0.015) 
0.726 
(0.016) 
0.682 
(0.002) 
1.191 
(0.03) 8.435 
0.764 
(0.013) 1* - -0.001 0.001 
 CVA 
5.059 
(0.013) 
0.443 
(0.01) 
0.442 
(0) 
25.788 
(0.134) 182.680 0 (0) 0.960 - 0 0.947 
 
Mean 
Imputation 
5.706 
(0.017) 
0.574 
(0.013) 
0.535 
(0.002) 
32.886 
(0.196) 232.962 0 (0) 0.602 original data 0 1.080 
         imputed data 0 0.044 
 
Missing 
Indicator 
5.528 
(0.021) 
0.578 
(0.013) 
0.568 
(0.001) 
30.890 
(0.237) 218.819 0 (0) 0.352 full data -0.001 0.954 
          observed part -0.001 0 
         missing part -0.001 1.704 
MNAR CC 
-1.084 
(0.014) 
0.675 
(0.015) 
0.682 
(0.002) 
1.629  
(0.033) 11.538 
0.631 
(0.015) 1* - -0.005 -0.004 
 CVA 
5.059 
(0.013) 
0.435 
(0.01) 
0.443 
(0) 
25.783 
(0.132) 182.646 0 (0) 0.960 - 0 0.947 
 
Mean 
Imputation 
5.689 
(0.018) 
0.592 
(0.013) 
0.559 
(0.001) 
32.711 
(0.202) 231.723 0 (0) 0.557 original data 0 1.078 
         imputed data 0 0.045 
 
Missing 
Indicator 
5.534 
(0.021) 
0.582 
(0.013) 
0.577 
(0.001) 
30.958 
(0.239) 219.305 0 (0) 0.345 full data 0 0.962 
         observed part 0 0 
         missing part 0 1.725 
*The percentage of treated patients being matched using CC is calculated from complete cases. 
 
  
Table A2. Percentage of treated subjects matched and standardized difference of covariates 
after matching in various multiple imputation (MI) strategies. For INT-across and INT-across2, 
standardized differences were also calculated on the observed and missing part of the imputed 
data separately. 
     Post-matching standardized difference 
 MI Strategy   Full Data  Imputed Data  Observed Part  Missing Part 
MDM Imputation Integration 
Percentage 
Matched 
 
X1 X2 
 
X1 X2 
 
X1 X2 
 
X1 X2 
MCAR           
   Auxiliary variable not included in imputation model           
 MI-derPassive INT-within 0.652  0 0.126  0 0  - -  - - 
  INT-across 0.633  -0.002 0.008  -0.002 0.006  0.036 -0.114  -0.046 0.125 
  INT-across2 0.636  -0.002 0.012  -0.002 0.010  0.039 -0.108  -0.048 0.127 
 MI-regActive INT-within 0.791  0.128 0.600  0.128 -0.127  - -  - - 
  INT-across 0.722  -0.004 0.345  -0.004 0.010  0.010 0.003  -0.019 0.022 
 MI-redActive INT-within 0.792  0 0.656  0 0  - -  - - 
  INT-across 0.738  0 0.345  0 0.009  0.004 -0.002  -0.004 0.021 
  INT-across2 0.782  0 0.430  0 0.045  0.001 0.001  -0.002 0.079 
   Auxiliary variable included in imputation model           
 MI-derPassive INT-within 0.655  0 0.024  0 0  - -  - - 
  INT-across 0.652  0.006 -0.008  0.006 -0.001  -0.115 -0.088  0.098 0.066 
  INT-across2 0.653  0.010 -0.011  0.010 -0.003  -0.123 -0.087  0.110 0.062 
 MI-regActive INT-within 0.659  0.006 0.040  0.006 -0.011  - -  - - 
  INT-across 0.653  -0.028 0.025  -0.028 0.010  -0.122 0.053  0.049 -0.039 
 MI-redActive INT-within 0.659  0 0.051  0 0  - -  - - 
  INT-across 0.653  -0.031 0.029  -0.031 0.014  -0.203 0.086  0.110 -0.059 
  INT-across2 0.652  -0.043 0.040  -0.043 0.026  -0.214 0.112  0.100 -0.061 
MAR1          
   Auxiliary variable not included in imputation model          
 MI-derPassive INT-within 0.656  0 0.114  0 0  - -  - - 
  INT-across 0.617  0.002 -0.028  0.002 -0.015  -0.748 -1.105  0.205 0.647 
  INT-across2 0.621  0.008 -0.034  0.008 -0.021  -0.746 -1.109  0.201 0.645 
 MI-regActive INT-within 0.877  0.368 0.752  0.368 0.322  NA NA  NA NA 
  INT-across 0.666  0.562 0.531  0.562 0.344  -0.160 -0.397  0.714 0.708 
 MI-redActive INT-within 0.772  0 0.483  0 -0.006  - -  - - 
  INT-across 0.628  0.002 0.031  0.002 -0.178  -0.746 -1.013  0.241 0.466 
  INT-across2 0.670  0.003 0.219  0.003 -0.029  -0.780 -0.84  0.260 0.517 
   Auxiliary variable included in imputation model           
 MI-derPassive INT-within 0.666  0 0.065  0 -0.001  - -  - - 
  INT-across 0.647  0.026 -0.031  0.026 -0.069  -0.895 -1.010  0.467 0.404 
  INT-across2 0.652  0.022 -0.027  0.022 -0.060  -0.953 -0.974  0.519 0.375 
 MI-regActive INT-within 0.785  0.351 0.420  0.351 0.338  - -  - - 
  INT-across 0.745  0.386 0.382  0.386 0.321  -0.672 -0.663  0.856 0.741 
 MI-redActive INT-within 0.669  0 0.085  0 -0.001  - -  - - 
  INT-across 0.643  0.012 -0.015  0.012 -0.069  -0.921 -1.008  0.460 0.405 
  INT-across2 0.651  0.013 -0.016  0.013 -0.061  -0.972 -0.982  0.506 0.384 
MAR2A           
   Auxiliary variable not included in imputation model           
 MI-derPassive INT-within 0.754  0 0.379  0 0  - -  - - 
  INT-across 0.686  0 0.146  0 -0.017  -0.390 -1.182  0.226 0.558 
  INT-across2 0.695  0 0.171  0 -0.016  -0.392 -1.185  0.212 0.563 
 MI-regActive INT-within 0.881  0.076 0.698  0.076 0.078  - -  - - 
  INT-across 0.571  0.026 0.428  0.026 0.021  -0.038 -0.472  0.020 0.204 
 MI-redActive INT-within 0.863  0 0.656  0 0  - -  - - 
  INT-across 0.734  0 0.348  0 -0.095  -0.331 -0.990  0.107 0.221 
  INT-across2 0.780  0 0.396  0 -0.090  -0.403 -1.061  0.140 0.245 
   Auxiliary variable included in imputation model           
 MI-derPassive INT-within 0.669  0 0.071  0 -0.001  - -  - - 
  INT-across 0.652  -0.014 0.013  -0.014 -0.030  -0.441 -1.283  0.294 0.546 
  INT-across2 0.653  -0.025 0.023  -0.025 -0.019  -0.473 -1.257  0.308 0.541 
 MI-regActive INT-within 0.729  0.122 0.248  0.122 0.166  - -  - - 
  INT-across 0.701  0.131 0.177  0.131 0.126  -0.374 -1.061  0.510 0.614 
 MI-redActive INT-within 0.672  0 0.084  0 -0.001  - -  - - 
  INT-across 0.652  -0.018 0.017  -0.018 -0.032  -0.476 -1.230  0.341 0.480 
  INT-across2 0.652  -0.026 0.024  -0.026 -0.023  -0.506 -1.203  0.361 0.465 
MNAR           
   Auxiliary variable not included in imputation model           
 MI-derPassive INT-within 0.754  0 0.377  0 0  - -  - - 
  INT-across 0.686  0 0.143  0 -0.017  -0.413 -1.245  0.233 0.571 
  INT-across2 0.694  0 0.168  0 -0.017  -0.416 -1.247  0.219 0.576 
 MI-regActive INT-within 0.888  0.117 0.733  0.117 0.107  - -  NA NA 
  INT-across 0.524  0.041 0.437  0.041 0.032  0.066 -0.410  -0.045 0.179 
 MI-redActive INT-within 0.863  0 0.652  0 0  - -  - - 
  INT-across 0.729  0 0.329  0 -0.107  -0.346 -1.080  0.093 0.229 
  INT-across2 0.776  0 0.381  0 -0.099  -0.418 -1.142  0.132 0.256 
   Auxiliary variable included in imputation model           
 MI-derPassive INT-within 0.671  0 0.079  0 -0.001  - -  - - 
  INT-across 0.652  -0.012 0.011  -0.012 -0.039  -0.457 -1.339  0.301 0.542 
  INT-across2 0.652  -0.022 0.021  -0.022 -0.029  -0.488 -1.310  0.317 0.531 
 MI-regActive INT-within 0.747  0.204 0.300  0.204 0.208  - -  - - 
  INT-across 0.709  0.240 0.246  0.240 0.184  -0.294 -1.027  0.623 0.636 
 MI-redActive INT-within 0.675  0 0.096  0 -0.001  NA NA  NA NA 
  INT-across 0.652  -0.012 0.011  -0.012 -0.047  -0.494 -1.281  0.364 0.455 
  INT-across2 0.652  -0.020 0.019  -0.020 -0.037  -0.528 -1.251  0.387 0.441 
 
Table A3. Bias, standard error mean squared error (MSE), relative mean squared error (rMSE), 
and coverage (calculated using bootstrap standard error) results using various multiple 
imputation (MI) strategies in MCAR, MAR1, and MNAR. (Monte Carlo standard errors in 
parentheses).  
MI Strategy  Standard Error    
Imputation Integration Bias Empirical Bootstrap MSE rMSE Coverage 
MCAR 
Auxiliary variable not included in imputation model 
  MI-derPassive INT-within -0.024 (0.012) 0.381 (0.009) 0.395 (0.001) 0.146 (0.006) 1.034 1 (0) 
 INT-across -0.796 (0.013) 0.424 (0.009) 0.418 (0.001) 0.814 (0.022) 5.766 0.569 (0.016) 
 INT-across2 0.008 (0.017) 0.534 (0.012) 0.539 (0.002) 0.285 (0.013) 2.019 1 (0) 
MI-regActive INT-within 3.224 (0.015) 0.489 (0.011) 0.508 (0.002) 10.636 (0.103) 75.345 0 (0) 
 INT-across 0.870 (0.028) 0.882 (0.020) 0.813 (0.004) 1.534 (0.055) 10.867 1 (0) 
MI-redActive INT-within 3.309 (0.013) 0.405 (0.009) 0.438 (0.001) 11.113 (0.087) 78.724 0 (0) 
 INT-across 0.851 (0.029) 0.926 (0.021) 0.807 (0.004) 1.580 (0.057) 11.193 1 (0) 
 INT-across2 0.012 (0.017) 0.541 (0.012) 0.536 (0.001) 0.293 (0.013) 2.076 1 (0) 
Auxiliary variable included in imputation model 
   MI-derPassive INT-within 0.095 (0.011) 0.359 (0.008) 0.359 (0.001) 0.138 (0.006) 0.978 1 (0)  
 INT-across 0.046 (0.012) 0.388 (0.009) 0.390 (0.001) 0.152 (0.007) 1.077 1 (0) 
 INT-across2 -0.005 (0.017) 0.55 (0.012) 0.547 (0.001) 0.303 (0.013) 2.146 1 (0) 
MI-regActive INT-within 0.241 (0.011) 0.358 (0.008) 0.363 (0.001) 0.186 (0.008) 1.318 1 (0) 
 INT-across 0.231 (0.012) 0.384 (0.009) 0.405 (0.001) 0.200 (0.009) 1.417 1 (0) 
MI-redActive INT-within 0.247 (0.011) 0.356 (0.008) 0.361 (0.001) 0.188 (0.008) 1.332 1 (0) 
 INT-across 0.221 (0.012) 0.387 (0.009) 0.398 (0.001) 0.198 (0.008) 1.403 1 (0) 
 INT-across2 0.003 (0.017) 0.534 (0.012) 0.551 (0.001) 0.285 (0.013) 2.019 1 (0) 
MAR1 
Auxiliary variable not included in imputation model 
  MI-derPassive INT-within 0.038 (0.014) 0.454 (0.01) 0.446 (0.001) 0.207 (0.011) 1.466 1 (0) 
 INT-across -0.176 (0.016) 0.497 (0.011) 0.472 (0.002) 0.278 (0.012) 1.969 1 (0) 
 INT-across2 -2.859 (0.024) 0.770 (0.017) 0.757 (0.003) 8.764 (0.14) 62.083 0 (0) 
MI-regActive INT-within 2.471 (0.043) 1.345 (0.03) 1.463 (0.007) 7.913 (0.174) 56.055 0.823 (0.012) 
 INT-across 5.275 (0.173) 5.473 (0.122) 4.719 (0.033) 57.746 (2.605) 409.068 0.915 (0.009) 
MI-redActive INT-within 2.557 (0.045) 1.414 (0.032) 1.405 (0.006) 8.534 (0.183) 60.454 0.719 (0.014) 
 INT-across 0.465 (0.032) 1.013 (0.023) 0.926 (0.005) 1.240 (0.076) 8.784 1 (0) 
 INT-across2 -2.633 (0.025) 0.792 (0.018) 0.772 (0.003) 7.558 (0.132) 53.540 0 (0) 
Auxiliary variable included in imputation model 
   MI-derPassive INT-within 0.319 (0.012) 0.395 (0.009) 0.376 (0.001) 0.258 (0.01) 1.828 1 (0) 
 INT-across 0.067 (0.013) 0.398 (0.009) 0.385 (0.001) 0.163 (0.008) 1.155 1 (0) 
 INT-across2 -2.904 (0.024) 0.771 (0.017) 0.744 (0.003) 9.028 (0.141) 63.954 0 (0) 
MI-regActive INT-within 0.502 (0.014) 0.449 (0.01) 0.465 (0.001) 0.453 (0.022) 3.209 1 (0) 
 INT-across 4.096 (0.176) 5.572 (0.125) 4.702 (0.040) 47.793 (2.478) 338.561 0.948 (0.007) 
MI-redActive INT-within 0.461 (0.013) 0.409 (0.009) 0.421 (0.001) 0.380 (0.016) 2.692 1 (0) 
 INT-across 0.059 (0.013) 0.418 (0.009) 0.406 (0.001) 0.178 (0.008) 1.261 1 (0) 
 INT-across2 -2.860 (0.024) 0.770 (0.017) 0.768 (0.003) 8.773 (0.14) 62.147 0 (0) 
MNAR 
Auxiliary variable not included in imputation model 
  MI-derPassive INT-within 1.487 (0.016) 0.515 (0.012) 0.470 (0.002) 2.476 (0.052) 17.540 0.001 (0.001) 
 INT-across 1.096 (0.015) 0.485 (0.011) 0.473 (0.002) 1.437 (0.037) 10.180 0.103 (0.01) 
 INT-across2 -1.345 (0.021) 0.675 (0.015) 0.658 (0.003) 2.264 (0.06) 16.038 0.332 (0.015) 
MI-regActive INT-within 3.384 (0.016) 0.498 (0.011) 0.541 (0.004) 11.701 (0.111) 82.889 0 (0) 
 INT-across 2.371 (0.062) 1.953 (0.044) 2.255 (0.050) 9.430 (0.793) 66.801 0.666 (0.015) 
MI-redActive INT-within 3.404 (0.016) 0.519 (0.012) 0.539 (0.007) 11.860 (0.119) 84.015 0 (0) 
 INT-across 1.878 (0.021) 0.661 (0.015) 0.719 (0.007) 3.963 (0.092) 28.074 0.1 (0.009) 
 INT-across2 -1.261 (0.02) 0.637 (0.014) 0.646 (0.002)  1.996 (0.054) 14.139 0.483 (0.016) 
Auxiliary variable included in imputation model 
   MI-derPassive INT-within 0.408 (0.012) 0.377 (0.008) 0.380 (0.001) 0.309 (0.011) 2.189 1 (0) 
 INT-across 0.042 (0.012) 0.382 (0.009) 0.378 (0.001) 0.148 (0.007) 1.048 1 (0) 
 INT-across2 -1.367 (0.021) 0.679 (0.015) 0.667 (0.003) 2.33 (0.062) 16.506 0.323 (0.015) 
MI-regActive INT-within 0.490 (0.013) 0.398 (0.009) 0.406 (0.001) 0.398 (0.015) 2.819 1 (0) 
 INT-across 2.505 (0.159) 5.024 (0.112) 4.295 (0.054) 31.492 (2.419) 223.087 0.957 (0.006) 
MI-redActive INT-within 0.480 (0.012) 0.387 (0.009) 0.392 (0.001) 0.380 (0.014) 2.692 1 (0) 
 INT-across 0.045 (0.013) 0.396 (0.009) 0.389 (0.001) 0.159 (0.007) 1.126 1 (0) 
 INT-across2 -1.325 (0.021) 0.661 (0.015) 0.673 (0.002) 2.191 (0.058) 15.521 0.455 (0.016) 
 
 
 
  
Table A4. Bias, standard error mean squared error (MSE), relative mean squared error (rMSE), 
and coverage calculated using MI-regPassive and MI-derPassive when 𝑋) was missing MAR2B 
and 𝑍@A was missing under various missing data mechanisms (aux_MCAR, aux_MAR1, and 
aux_MAR2). Monte Carlo standard errors are in parentheses. 
MI Strategy  Standard Error    
Imputation Integration Bias Empirical Bootstrap MSE rMSE Coverage 
Fully observed aux      
   MI-derPassive INT-within -0.019 (0.012) 0.381 (0.009) 0.378 (0.001) 0.146 (0.006) 1.032 1 (0) 
 INT-across -0.205 (0.012) 0.394 (0.009) 0.381 (0.001) 0.197 (0.008) 1.394 1 (0) 
 INT-across2 -1.016 (0.021) 0.652 (0.015) 0.682 (0.003) 1.457 (0.048) 10.319 0.993 (0.003) 
aux_MCAR 
Default imputation order 
  MI-derPassive INT-within 0.085 (0.012) 0.381 (0.009) 0.550 (0.006) 0.152 (0.007) 1.079 1 (0) 
 INT-across -0.152 (0.013) 0.402 (0.009) 0.499 (0.004) 0.184 (0.008) 1.304 1 (0) 
 INT-across2 -0.982 (0.021) 0.671 (0.015) 0.683 (0.002) 1.415 (0.048) 10.024 1 (0) 
MI-regPassive INT-within 0.087 (0.012) 0.378 (0.008) 0.533 (0.006) 0.150 (0.007) 1.065 1 (0) 
 INT-across -0.143 (0.013) 0.413 (0.009) 0.489 (0.003) 0.191 (0.008) 1.352 1 (0) 
 INT-across2 -0.996 (0.021) 0.666 (0.015) 0.685 (0.002) 1.436 (0.046) 10.173 1 (0) 
Reverse imputation order 
   MI-derPassive INT-within 0.028 (0.012) 0.382 (0.009) 0.550 (0.006) 0.147 (0.006) 1.040 1 (0)  
 INT-across -0.191 (0.012) 0.391 (0.009) 0.500 (0.004) 0.189 (0.008) 1.340 1 (0) 
 INT-across2 -1.01 (0.021) 0.671 (0.015) 0.682 (0.002) 1.471 (0.047) 10.418 0.999 (0.001) 
   MI-regPassive INT-within -0.196 (0.012) 0.372 (0.008) 0.532 (0.006) 0.177 (0.008) 1.251 1 (0) 
 INT-across -0.232 (0.013) 0.405 (0.009) 0.489 (0.003) 0.218 (0.009) 1.543 1 (0) 
 INT-across2 -1.002 (0.021) 0.668 (0.015) 0.684 (0.002) 1.450 (0.045) 10.273 1 (0) 
aux_MAR1 
Default imputation order 
  MI-derPassive INT-within 0.185 (0.012) 0.393 (0.009) 0.550 (0.006) 0.189 (0.008) 1.337 1 (0)  
 INT-across 0.011 (0.013) 0.414 (0.009) 0.499 (0.004) 0.171 (0.008) 1.211 1 (0) 
 INT-across2 -1.017 (0.021) 0.651 (0.015) 0.684 (0.002) 1.458 (0.045) 10.329 1 (0) 
MI-regPassive INT-within 0.205 (0.013) 0.396 (0.009) 0.533 (0.006) 0.199 (0.008) 1.410 1 (0) 
 INT-across 0.014 (0.013) 0.414 (0.009) 0.488 (0.003) 0.171 (0.008) 1.213 1 (0) 
 INT-across2 -1.007 (0.021) 0.656 (0.015) 0.685 (0.002) 1.444 (0.045) 10.231 1 (0) 
Reverse imputation order 
   MI-derPassive INT-within 0.091 (0.012) 0.391 (0.009) 0.550 (0.006) 0.161 (0.007) 1.140 1 (0)  
 INT-across -0.069 (0.013) 0.408 (0.009) 0.500 (0.004) 0.171 (0.007) 1.213 1 (0) 
 INT-across2 -0.993 (0.021) 0.661 (0.015) 0.684 (0.002) 1.422 (0.045) 10.071 1 (0) 
   MI-regPassive INT-within -0.129 (0.012) 0.379 (0.008) 0.534 (0.006) 0.160 (0.007) 1.135 1 (0) 
 INT-across -0.087 (0.013) 0.403 (0.009) 0.489 (0.003) 0.170 (0.008) 1.201 1 (0) 
 INT-across2 -0.982 (0.021) 0.650 (0.015) 0.685 (0.002) 1.385 (0.043) 9.813 1 (0) 
aux_MAR2 
Default imputation order 
  MI-derPassive INT-within -0.060 (0.012) 0.390 (0.009) 0.550 (0.006) 0.155 (0.006) 1.100 1 (0)  
 INT-across -0.374 (0.013) 0.412 (0.009) 0.500 (0.004) 0.310 (0.012) 2.194 1 (0) 
 INT-across2 -0.994 (0.021) 0.660 (0.015) 0.683 (0.002) 1.422 (0.044) 10.076 1 (0) 
MI-regPassive INT-within -0.049 (0.013) 0.396 (0.009) 0.533 (0.006) 0.159 (0.006) 1.128 1 (0) 
 INT-across -0.369 (0.013) 0.408 (0.009) 0.489 (0.003) 0.302 (0.012) 2.141 1 (0) 
 INT-across2 -1.001 (0.021) 0.656 (0.015) 0.685 (0.002) 1.431 (0.043) 10.137 0.999 (0.001) 
Reverse imputation order 
   MI-derPassive INT-within -0.068 (0.012) 0.390 (0.009) 0.549 (0.006) 0.157 (0.006) 1.111 1 (0)  
 INT-across -0.369 (0.013) 0.412 (0.009) 0.500 (0.004) 0.305 (0.012) 2.163 1 (0) 
 INT-across2 -0.996 (0.021) 0.652 (0.015) 0.683 (0.002) 1.416 (0.043) 10.032 0.999 (0.001) 
   MI-regPassive INT-within -0.308 (0.012) 0.391 (0.009) 0.533 (0.006) 0.248 (0.010) 1.754 1 (0) 
 INT-across -0.414 (0.013) 0.411 (0.009) 0.489 (0.003) 0.340 (0.013) 2.410 1 (0) 
 INT-across2 -0.987 (0.021) 0.665 (0.015) 0.685 (0.002) 1.417 (0.043) 10.039 1 (0) 
 
 
 
